Select Country

Select a country to view information on local trademark law


Countries
A-E  F-J  K-O  P-T  U-Z

Multinational Agreements
EUIPO  WIPO
AIPO/OAPI  ARIPO
Enter Client Voucher:  info

Get Listed

Promote your expertise to IP professionals worldwide.
read more

Subscribe to Free Newsletter

To keep updated on the latest amendments to international trademark laws click here

Articles

Print this page
Apr 03, 2013
Vikrant Rana, S.S. Rana & Co., India

Novartis’s Appeal for Glivec Patent Dismissed


Vikrant Rana, S.S. Rana & Co., India In what would be touted as the landmark judgment in all the years to come and for the Pharma Industry as well as the Indian Patenting System, the Supreme Court of India has rejected Novartis’s plea on its blood cancer drug Glivec and denied patent to it. The drug was not considered to be patentable as per the provisions of Section 3(d) that draws a distinction between “ever-greening” and incremental innovation. The Supreme Court rejected the claims of Swiss pharma giant stating that  read more